Ronald G. Tilton
- Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research 23
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes 19
- Physiology top 0.5%
- Nitric Oxide and Endothelin Effects 18
- Biochemical effects in animals 10
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 10
- Neurology top 1%
-
- Aldose Reductase and Taurine 12
-
- Cardiac Ischemia and Reperfusion 8
-
- Angiogenesis and VEGF in Cancer 7
- Co-authors
- Joseph R. WilliamsonCharles KiloYasuo IdoAn S. De VrieseThomas P. MiskoJohn A. CorbettKatherine ChangMichael L. McDaniel
- Journals
- Journal of Clinical Investigation (4 papers)The Journal of Experimental Medicine (2 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesDenmarkBelgium
In The Last Decade
Ronald G. Tilton
127 papers receiving 10.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Clinical Biochemistry 1.8k
- Nephrology 1.4k
- Physiology 3.1k
- Ophthalmology 926
- Neurology 767
Countries citing papers authored by Ronald G. Tilton
This map shows the geographic impact of Ronald G. Tilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald G. Tilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald G. Tilton more than expected).
Fields of papers citing papers by Ronald G. Tilton
This network shows the impact of papers produced by Ronald G. Tilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald G. Tilton. The network helps show where Ronald G. Tilton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ronald G. Tilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 56 | |
| 2 | 2009 | 2 | |
| 3 | 2009 | 5 | |
| 4 | 2009 | 30 | |
| 5 | 2007 | 45 | |
| 6 | 2007 | 54 | |
| 7 | 2006 | 93 | |
| 8 | 2006 | 60 | |
| 9 | A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma. | 2003 | 5 |
| 10 | 2001 | 18 | |
| 11 | Endotoxin-induced leukocyte accumulation in aqueous fluid of rats is decreased by a small molecule selectin antagonist | 1996 | 1 |
| 12 | Links between retinal vascular dysfunction induced by elevated glucose levels and VEGF | 1996 | 3 |
| 13 | 1996 | 126 | |
| 14 | 1993 | 132 | |
| 15 | 1993 | 138 | |
| 16 | Selective inhibition of the inducible nitric oxide synthase by aminoguanidinebreakdown → | 1993 | 640 |
| 17 | 1992 | 9 | |
| 18 | 1991 | 4 | |
| 19 | 1989 | 20 | |
| 20 | 1989 | 50 |
About Ronald G. Tilton
Ronald G. Tilton is a scholar working on Clinical Biochemistry, Nephrology and Neurology, having authored 127 papers that have together received 10.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (23 papers), Chronic Kidney Disease and Diabetes (19 papers), Nitric Oxide and Endothelin Effects (18 papers), Aldose Reductase and Taurine (12 papers), Retinal Diseases and Treatments (10 papers), Biochemical effects in animals (10 papers), Cardiac Ischemia and Reperfusion (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). The work is most often cited by research in Clinical Biochemistry (1.8k citations), Nephrology (1.4k citations) and Physiology (3.1k citations). Ronald G. Tilton has collaborated with scholars based in United States, Denmark and Belgium. Frequent co-authors include Joseph R. Williamson, Charles Kilo, Yasuo Ido, An S. De Vriese, Thomas P. Misko, John A. Corbett, Katherine Chang, Michael L. McDaniel, Khalid S. Hasan and Norbert Lameire. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.